Today: 17 May 2026
SoFi stock slips as options traders bet on a big earnings swing
6 January 2026
1 min read

SoFi stock slips as options traders bet on a big earnings swing

NEW YORK, Jan 6, 2026, 10:27 (EST)

SoFi Technologies’ shares fell 7.2% to $27.17 in morning trade on Tuesday after opening at $29.23. The stock touched $29.32 earlier in the session before sliding to $27.08.

The move follows a sharp jump a day earlier. SoFi shares rose 6.6% on Monday, hitting $29.86, on volume of 73.6 million shares, MarketBeat reported.

Options traders have tilted bullish ahead of SoFi’s Jan. 30 earnings report. TheFly said 104,387 call options traded — about three times expected volume — while implied volatility, which reflects how big a move traders price in, climbed to 64.69%. The put-to-call ratio was 0.31, meaning calls outnumbered puts, and the busiest contracts were weekly calls expiring Jan. 9 with $28 and $29 strike prices.

TipRanks said options prices implied a 13.73% move in either direction after results. The site said analysts expect fourth-quarter revenue to fall about 3% to about $978.6 million and earnings per share, a measure of profit, to ease to $0.11. Wall Street’s consensus rating was Hold, with an average price target of $28.79, TipRanks said.

Barclays analyst Terry Ma raised his price target on SoFi to $28 from $23 and kept an equal weight rating, TheFly reported. Ma said a “benign” credit environment should support loan growth and forecast a stronger mortgage origination market in 2026. TipRanks

A Motley Fool commentary carried by Nasdaq said SoFi shares fell 12% in December, citing S&P Global Market Intelligence data, and pointed to a premium valuation and softer crypto prices. The piece said SoFi has been rolling out new products such as cryptocurrency trading and a stablecoin, but noted the stock traded at 53 times trailing 12-month earnings and about four times book value.

A regulatory filing showed underwriters exercised a 30-day option in SoFi’s recent stock sale on Jan. 2, and the company completed the additional share issuance on Jan. 5. The move lifted the total shares sold in the offering to 57,754,660 at $27.50 per share, implying gross proceeds of about $1.6 billion before fees.

In a Seeking Alpha note on Tuesday, Tangerine Tan Capital wrote that SoFi’s lending and financial services units are growing faster than its technology platform. The author cited 76% year-on-year growth in financial services net sales and 23% growth in lending, while saying the personal-loan net charge-off ratio improved even as total charge-offs — loans written off as uncollectable — rose with higher loan volumes.

Stock Market Today

  • Berkshire Hathaway CEO Greg Abel Revamps Portfolio with Major Stock Changes
    May 16, 2026, 7:29 PM EDT. Berkshire Hathaway, under new CEO Greg Abel, has significantly overhauled its equity portfolio in Q1, highlighted by a 224% increase in Alphabet shares, now Berkshire's seventh largest holding valued at $16.6 billion. Abel added Delta Air Lines and Macy's, while cutting multiple stocks, including a near-total sale of Constellation Brands and complete exit from Amazon shares. The largest reduction by value was in Chevron, cut by 35%, worth over $8 billion. The reshuffle marks a shift away from holdings linked to former portfolio manager Todd Combs, indicating a strategic realignment under Abel's leadership. Alphabet has gained 38% since the quarter ended.

Latest articles

Joby Aviation Slides Monday With Air-Taxi in Focus

Joby Aviation Slides Monday With Air-Taxi in Focus

17 May 2026
Joby Aviation shares closed Friday at $10.36, down 2.6% for the day and 4.7% for the week. CEO JoeBen Bevirt-linked trusts sold over 421,000 shares under a preset 10b5-1 plan, filings showed. The stock traded between $10.04 and $10.58 during a volatile week. Broader markets and eVTOL sector peers also declined.
ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

ImmunityBio’s BCG Agreement Puts Monday’s Trading in Focus

17 May 2026
ImmunityBio closed at $7.97 Friday, down 2.2% after announcing exclusive U.S. rights to Japan BCG Laboratory’s Tokyo-172 strain for bladder cancer therapy. The Tokyo strain remains investigational in the U.S. and is not FDA-approved. Nasdaq was closed for the weekend; the next trading session is Monday. ImmunityBio’s Q1 product revenue rose to $44.2 million with $380.9 million in cash and securities.
Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

Infleqtion Stock Just Took a Hit After Record Revenue — What Could Move INFQ Next

17 May 2026
Infleqtion Inc. shares fell 10.95% to $12.44 Friday, capping a rough week for quantum tech stocks. The company reported a first-quarter net loss of $30.3 million on $9.5 million in revenue, with 85% from government contracts. Infleqtion launched a new RF sensing platform and raised its 2026 revenue outlook, but warned of continued operating losses.
Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

Synopsys Shares Dropped for the Week, Looking to May 27 for Direction

17 May 2026
Synopsys shares fell 1.49% Friday to $502.42, ending the week down 2.72% amid a broad tech selloff and news that Coatue Management cut its stake by 54%. The Nasdaq Composite dropped 1.54% Friday, while the Philadelphia semiconductor index slid 4%. Synopsys will report fiscal Q2 results after the market closes on May 27. Wells Fargo and Citigroup raised their price targets for the stock earlier in the week.
Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings
Previous Story

Tesla stock slides on Europe sales slump as BYD gains; traders eye Jan. 28 earnings

SLB Limited stock slips as Evercore upgrade meets Freedom downgrade after Venezuela rally
Next Story

SLB Limited stock slips as Evercore upgrade meets Freedom downgrade after Venezuela rally

Go toTop